PharmaBoardroom

J.P. Morgan Healthcare Conference 2022: Glass Half Full

David H. Crean summarizes the recent 40th annual J.P. Morgan Healthcare Conference 2022 that was held in a virtual format. Crean underlines the…

The Cell & Gene Therapy Market: Excitement Abounds

David H. Crean, Managing General Partner for Coast BioVentures, updates and highlights the latest trends in the cell and gene therapy market for deal…

5 Things to Know about the Life Sciences in Catalonia

A rundown of five things to know about the healthcare and life sciences industry in Catalonia. Nestled in Northeastern Spain and bordering France,…

Marianne Pilgaard – CEO, Trial Nation, Denmark

Trial Nation is a non-profit public-private partnership organisation consisting of all five Danish regions, the Ministry of Industry, Business and…

Estève Speranza – Managing Director Nordic Countries,…

Servier's Estève Speranza outlines the rationale behind the French group's reorganisation in the Nordic countries, how the global shift towards…

Top 4 Priorities for Turkey’s Minister of Health

Overseeing healthcare for a population of over 80 million, Turkey’s Ministry of Health was put under the spotlight during the COVID-19 pandemic.…

UK Pharma News: AstraZeneca Creates COVID Vaccines Unit; GSK…

The latest news from UK pharma, including AstraZeneca’s decision to create a dedicated business unit for its COVID-19 vaccines, GSK’s raised…

Jens Nielsen – CEO, BioInnovation Institute (BII), Denmark

The BioInnovation Institute (BII) is an initiative from the Novo Nordisk Foundation which aims to support entrepreneurial researchers and early-stage…

Facing Adversity, Bayer Ploughs on With Big Investments

After a challenging 2020, and with more hurdles in sight, Bayer has been on an investment spree with a USD 2 billion acquisition of a San Diego-based…